Nordea Mortgage Bank Plc
Nordea Mortgage Bank Plc: Half-year report 2022

Stock exchange release 18 July 2022

Nordea Mortgage Bank Plc: Half-year financial report January-June 2022

Nordea Mortgage Bank Plc’s Half-year financial report and Alternative performance measures have been published. The documents are attached to this release and they are available on the Internet at http://www.nordea.com/en/investor-relations/reports-and-presentations/. Only information having material influence on the value of securities is included in this stock exchange release.

This statutory half-year report covers the operations of the legal entity Nordea Mortgage Bank Plc. Nordea Mortgage Bank Plc is a wholly owned subsidiary of Nordea Bank Abp, the listed parent company of the whole Nordea Group. The half-year report of Nordea Bank Abp comprises the operations of the Nordea Group as a whole and gives the best overview of the Group.

Summary of the first half of 2022:

• The operating profit of Nordea Mortgage Bank amounted to EUR 65.2m
• Net interest income totalled EUR 139.5m
• Total operating income was EUR 157.0m
• Total operating expenses were EUR 83.9m.
• Net loan losses totalled EUR 7.9m.
• Loans to the public amounted to EUR 31,690.8m.
• Debt securities in issue totalled EUR 21,368.0m.
• The size of the cover pool was EUR 24,029.4m and overcollateralization 16.2%.

Helsinki, 18 July 2022
Nordea Mortgage Bank Plc
Board of Directors

Additional information:

Jussi Pajala, Chief Executive Officer + 358 40 545 3859
Heikki Jousi, Chief Financial Offic + 358 40 516 2971

Link: Nordea Mortgage Bank Plc, Half-year financial report January-June 2022
http://www.rns-pdf.londonstockexchange.com/rns/8087S_1-2022-7-18.pdf


Link: Nordea Mortgage Bank Plc, Alternative Performance Measures January-June 2022
http://www.rns-pdf.londonstockexchange.com/rns/8087S_2-2022-7-18.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.